Current Medicines

For more than 140 years, we have worked tirelessly to develop and deliver trusted medicines that meet real needs. Our growing portfolio of medicines includes treatments in the areas of cardiovascular, diabetes, men’s health, musculoskeletal, neuroscience and oncology.

New Zealand laws and regulations limit the amount of product information that we can provide to the general public via our website. We encourage patients wishing to obtain more detailed information about a Lilly product that has been prescribed to them, to speak to their healthcare professional.

The product information on this website is intended for New Zealand residents.

Diabetes

Humalog ® / Humalog ® Mix25 / Humalog ® Mix50 (insulin lispro) cartridges

Humalog ® (insulin lispro) vials

Humulin ®  R/Humulin ®  NPH/ Humulin ®  30/70 (biosynthetic human insulin) vials

Humulin ®  R/ Humulin ®  NPH/ Humulin ®  30/70 (biosynthetic human insulin) cartridges

Trulicity ® (dulaglutide)

Diabetes – In alliance with Boehringer Ingelheim

Jardiance ® * (empagliflozin)


Jardiamet ® * (empagliflozin / metformin hydrochloride)


* A licensed trademark of Boehringer Ingelheim

Men's Health

Cialis® (tadalafil)

Musculoskeletal

Evista® (raloxifene hydrochloride)

Forteo® (teriparatide of recombinant DNA origin)

Neuroscience

Prozac® (fluoxetine hydrochloride)

Strattera® (atomoxetine hydrochloride)

Zyprexa® (olanzapine) – Tablets and Wafers

Zyprexa® IM (olanzapine) – Injection

Zyprexa® Relprevv (olanzapine) long acting injectable

Oncology

Alimta® (pemetrexed)

PP-MG-NZ-0019 09/2021